Genentech oncology collaboration with GNS featured in TechEmergence

October 11, 2017 by Jon Walker Genentech, a member of the Roche Group, this summer announced their own collaboration with Cambridge, MA-based GNS Healthcare. GNS Healthcare’s mission statement is to use the latest innovations in machine learning to turn biomedical data into solutions and treatments. This collaboration’s first focus will also be on oncology, just like the IBM/Pfizer deal. Genentech […]

GNS Healthcare Announces Collaboration to Power Cancer Drug Development with REFS™ Causal Machine Learning and Simulation AI Platform

CAMBRIDGE, Mass.– June 19, 2017 – GNS Healthcare (GNS), a leading precision medicine company, today announced a collaboration with Genentech, a member of the Roche Group to leverage GNS REFS™ (Reverse Engineering and Forward Simulation) causal machine learning and simulation platform to power the development of novel cancer therapies. The GNS technology turns large and diverse […]

GNS Healthcare Strengthens Foothold in Clinical Care Management, Appoints Nationally Regarded Authorities to Strategic Advisory Board

CAMBRIDGE, Mass. – Sept. 28, 2015 – GNS Healthcare (GNS), a leading provider of analytics solutions for driving personalized interventions that improve population health, today announced the expansion of its Strategic Advisory Board (SAB). Joining the SAB are Susan Weaver, MD, former Chief Medical Officer of Blue Cross and Blue Shield of North Carolina; Robert […]